LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 63 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $47,000 | -23.0% | 170,945 | -2.0% | 0.00% | – |
| Q2 2022 | $61,000 | -58.2% | 174,454 | -19.3% | 0.00% | – |
| Q1 2022 | $146,000 | -71.1% | 216,116 | -1.1% | 0.00% | – |
| Q4 2021 | $506,000 | -48.8% | 218,609 | +1.3% | 0.00% | – |
| Q3 2021 | $988,000 | +0.6% | 215,736 | -2.4% | 0.00% | – |
| Q2 2021 | $982,000 | -86.3% | 221,148 | -77.5% | 0.00% | – |
| Q1 2021 | $7,164,000 | +3.9% | 984,011 | +8.9% | 0.00% | – |
| Q4 2020 | $6,895,000 | +5.5% | 903,727 | +25.5% | 0.00% | – |
| Q3 2020 | $6,538,000 | +10.7% | 719,959 | +3.1% | 0.00% | – |
| Q2 2020 | $5,908,000 | +140.1% | 698,367 | +40.2% | 0.00% | – |
| Q1 2020 | $2,461,000 | -32.4% | 498,149 | -1.4% | 0.00% | – |
| Q4 2019 | $3,638,000 | -27.9% | 505,280 | +8.2% | 0.00% | – |
| Q3 2019 | $5,048,000 | -14.0% | 467,121 | +3.4% | 0.00% | – |
| Q2 2019 | $5,873,000 | +62.1% | 451,723 | +23.2% | 0.00% | – |
| Q1 2019 | $3,623,000 | -7.7% | 366,644 | -2.9% | 0.00% | – |
| Q4 2018 | $3,927,000 | – | 377,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |